DeviceTalks Podcast Network

MassDevice’s Brian Johnson and CeQur's CEO Jim Peterson discuss Peterson’s personal connection to diabetes, and how that personal connection has impacted the company’s direction.

MassDevice reporter Brad Periello speaks with CEO and founder of NxStage Medical Jeff Burbank, Zoll CEO Richard Packer, ConforMIS CEO Philipp Lang, and Ocular Therapeutix CEO Amar Sawhney about what it takes to keep companies on the cutting edge, as well as their ups and downs as heads of major medtech companies.

Johnson & Johnson's Global Medical Solutions Group Worldwide Chairman Karen Licitra talks about her role within Johnson & Johnson and how she thinks the economics of healthcare and the medical device industry need to change in order to accommodate the future.

Former Kinetic Concepts CEO Catherine Burzik takes you inside the $6.1 billion merger of Kinetic Concepts with Apax Partners in 2011, the largest leveraged buyout since the fall of Lehman Brothers.

Medtronic CEO Omar Ishrak sat down with MassDevice's Brian Johnson to talk about his two years on the job at the Minneapolis-based medtech company. Ishrak shared his experiences, as well as the insights he has gained as Medtronic's CEO.

Semprus BioSciences Corp. hopes to reduce the 60,000 deaths and $11 billion in costs related to "surface failures" of vascular catheters with its Sustain technology for coating medical devices.

William Hawkins, former chairman and CEO of Medtronic Inc., dishes on mergers and acquisitions, the Food & Drug Administration and healthcare reform.

Dr. Thomas Fogarty, the founder of the Fogarty Institute for Innovation, discusses the investment climate for medical innovation, venture capital and explains why his passion for winemaking is actually an extension of his medical career.

Capsule Tech's newly appointed North America president Stuart Long tells MassDevice about the company's surging growth and what it means to be a "middleware" service provider.

Soteira CEO Larry Jasinski talks to MassDevice about overcoming the odds with spinal fusion devices and managing a 510(k) win even after the FDA switched things up mid-stream.

Covidien CEO Joe Almeida speaks at the MassDevice Big 100 Roundtable, July 11, 2011 about innovation, emerging markets and the worst mistake he's made in his professional career.

Two decades after pioneering the technology that became Lasik, Avedro Inc. CEO David Muller is working to make the procedure safer and more effective.

Neuronetics president & CEO Bruce Shook on treating an incurable psychiatric disorder, chasing reimbursement and turning psychiatrists into medical device proceduralists.

Alfred Mann Foundation CEO David Hankin tells MassDevice how to make an artificial nervous system using microstimulators that communicate wirelessly through the body.

After a stellar 2010, Michael Mussallem, CEO of Edwards Lifesciences Corp., is feeling bullish on transcatheter heart valves and the future of the Irvine, Calif.-based cardiac device maker.

Medical device company Abiomed's CEO Mike Minogue and Stu Randle, CEO of GI Dynamics, sit down with MassDevice.com editor Brad Perriello at the MassDevice Big 100 Roundtable East.

Johns Hopkins patient safety expert Peter Pronovost on medical errors, medical device data and the role medtech must accept in preventing needless deaths.

Allergan CEO David Pyott speaks at the 2012 MassDevice Big 100 West about why the Irvine, Calif.-based medical aesthetics company is selling its Lap-Band business, why Botox is so popular and what the medical device industry can learn from the world of aesthetics.

Three months before he took the reins at Boston Scientific, Mike Mahoney told MassDevice his thoughts on how he looked to turnaround the medical device giant in this podcast from the MassDevice Big 100 East